Michael L. Corman

1.6k total citations
13 papers, 1.3k citations indexed

About

Michael L. Corman is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Michael L. Corman has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in Michael L. Corman's work include Receptor Mechanisms and Signaling (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Phosphodiesterase function and regulation (4 papers). Michael L. Corman is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Phosphodiesterase function and regulation (4 papers). Michael L. Corman collaborates with scholars based in United States. Michael L. Corman's co-authors include Rodney C. Schnur, Anne W. Schmidt, Randall J. Gallaschun, F. David Tingley, Robert S. Mansbach, David W. Schulz, P A Seymour, Jonathan L. Doty, Michael F. Dee and Beth Cooper and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Michael L. Corman

13 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael L. Corman United States 11 777 385 336 192 183 13 1.3k
Brian L. Largent United States 15 638 0.8× 234 0.6× 162 0.5× 541 2.8× 100 0.5× 18 1.3k
Alan Robertson United Kingdom 22 473 0.6× 171 0.4× 241 0.7× 301 1.6× 425 2.3× 33 1.5k
Nathaniel G.N. Milton United Kingdom 20 466 0.6× 222 0.6× 202 0.6× 191 1.0× 28 0.2× 42 1.2k
Irmgard Wiesenberg Switzerland 17 584 0.8× 77 0.2× 117 0.3× 330 1.7× 194 1.1× 26 1.7k
Ludo Kennis Belgium 7 537 0.7× 90 0.2× 102 0.3× 555 2.9× 127 0.7× 12 1.1k
Joel B. Yudkovitz United States 16 439 0.6× 205 0.5× 109 0.3× 175 0.9× 106 0.6× 22 1.3k
Kazuyuki Tomisawa Japan 15 317 0.4× 154 0.4× 42 0.1× 271 1.4× 130 0.7× 51 846
R. Pellicciari Italy 17 341 0.4× 249 0.6× 67 0.2× 160 0.8× 155 0.8× 43 1.1k
Jeffrey W. Cramer United States 14 450 0.6× 116 0.3× 141 0.4× 346 1.8× 202 1.1× 20 1.3k
Anna Partyka Poland 26 883 1.1× 65 0.2× 357 1.1× 529 2.8× 539 2.9× 105 1.9k

Countries citing papers authored by Michael L. Corman

Since Specialization
Citations

This map shows the geographic impact of Michael L. Corman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Corman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Corman more than expected).

Fields of papers citing papers by Michael L. Corman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Corman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Corman. The network helps show where Michael L. Corman may publish in the future.

Co-authorship network of co-authors of Michael L. Corman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Corman. A scholar is included among the top collaborators of Michael L. Corman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Corman. Michael L. Corman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tilstam, Pathricia V., Georgios Pantouris, Michael L. Corman, et al.. (2019). A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity. Journal of Biological Chemistry. 294(49). 18522–18531. 29 indexed citations
2.
3.
4.
Verhoest, Patrick R., Michael L. Corman, Christopher J. Helal, et al.. (2009). Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy. Journal of Medicinal Chemistry. 52(24). 7946–7949. 45 indexed citations
5.
Schmidt, C J, Douglas S. Chapin, Michael L. Corman, et al.. (2008). Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia. Journal of Pharmacology and Experimental Therapeutics. 325(2). 681–690. 238 indexed citations
6.
Chen, Yuhpyng L., R. Scott Obach, John P. Braselton, et al.. (2008). 2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists. Journal of Medicinal Chemistry. 51(5). 1385–1392. 52 indexed citations
7.
Chen, Yuhpyng L., et al.. (2007). Thiazole-diamides as potent γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(20). 5518–5522. 10 indexed citations
8.
Chen, Yuhpyng L., Robert S. Mansbach, Steven M. Winter, et al.. (1997). Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine:  A Centrally Active Corticotropin-Releasing Factor1 Receptor Antagonist. Journal of Medicinal Chemistry. 40(11). 1749–1754. 93 indexed citations
9.
Schulz, David W., Robert S. Mansbach, Jeffrey Sprouse, et al.. (1996). CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.. Proceedings of the National Academy of Sciences. 93(19). 10477–10482. 308 indexed citations
10.
Schnur, Rodney C., Michael L. Corman, Randall J. Gallaschun, et al.. (1995). erbB-2 oncogene inhibition by geldanamycin derivatives: synthesis, mechanism of action, and structure-activity relationships. Journal of Medicinal Chemistry. 38(19). 3813–3820. 110 indexed citations
11.
Schnur, Rodney C., Michael L. Corman, Randall J. Gallaschun, et al.. (1995). Inhibition of the oncogene product p185erbB-2 in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. Journal of Medicinal Chemistry. 38(19). 3806–3812. 162 indexed citations
12.
Schnur, Rodney C. & Michael L. Corman. (1994). Tandem [3,3]-Sigmatropic Rearrangements in an Ansamycin: Stereospecific Conversion of an (S)-Allylic Alcohol to an (S)-Allylic Amine Derivative. The Journal of Organic Chemistry. 59(9). 2581–2584. 48 indexed citations
13.
Schnur, Rodney C. & Michael L. Corman. (1994). Preparation of 17‐amino‐22‐(4′‐azido‐3′‐125iodophenacyl)‐17‐demethoxygeldanamycin (1): An ansamycin for photoaffinity labeling. Journal of Labelled Compounds and Radiopharmaceuticals. 34(6). 529–535. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian L. Largent Breakdown of academic impact, for papers by Alan Robertson Breakdown of academic impact, for papers by Nathaniel G.N. Milton Breakdown of academic impact, for papers by Irmgard Wiesenberg Breakdown of academic impact, for papers by Ludo Kennis Breakdown of academic impact, for papers by Joel B. Yudkovitz Breakdown of academic impact, for papers by Kazuyuki Tomisawa Breakdown of academic impact, for papers by R. Pellicciari Breakdown of academic impact, for papers by Jeffrey W. Cramer Breakdown of academic impact, for papers by Anna Partyka
Rankless by CCL
2026